Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$529K Buy
16,804
+2,800
+20% +$88.2K 0.01% 858
2025
Q4
$413K Buy
14,004
+757
+6% +$21K 0.01% 909
2025
Q3
$334K Buy
13,247
+4,568
+53% +$111K 0.01% 969
2025
Q2
$212K Buy
+8,679
New +$201K ﹤0.01% 1102
2025
Q1
Sell
-12,217
Closed -$309K 1214
2024
Q4
$309K Sell
12,217
-15,446
-56% -$391K 0.01% 934
2024
Q3
$834K Sell
27,663
-5,745
-17% -$170K 0.02% 617
2024
Q2
$991K Buy
33,408
+5,745
+21% +$159K 0.02% 566
2024
Q1
$834K Sell
27,663
-7,089
-20% -$197K 0.02% 617
2023
Q4
$994K Sell
34,752
-2,479
-7% -$72.8K 0.03% 538
2023
Q3
$1.38M Buy
37,231
+2,909
+8% +$111K 0.05% 392
2023
Q2
$1.34M Buy
34,322
+11,455
+50% +$449K 0.05% 387
2023
Q1
$835K Sell
22,867
-8,757
-28% -$276K 0.03% 494
2022
Q4
$974K Buy
+31,624
New +$982K 0.05% 387

Other funds holding RTO

Ethic Inc's RTO Position: Q1 2026 in Review

Ethic Inc increased its Rentokil (RTO) stake by 20% in Q1 2026, buying an estimated $88.2K and bringing the position to 16,804 shares worth $529K. The position accounts for 0.01% of the portfolio, ranked #858.

Ethic Inc first reported a position in RTO in Q4 2022 and has held it in 13 quarters since. The position peaked at $1.38M in Q3 2023. 282 funds tracked by Wall St. Rank hold RTO as of Q1 2026.

  • Ethic Inc held 16,804 shares of Rentokil worth $529K as of Q1 2026.
  • Ethic Inc bought 2,800 Rentokil shares in Q1 2026, an estimated $88.2K.
  • Rentokil made up 0.01% of Ethic Inc's portfolio in Q1 2026, its #858 holding.
  • Ethic Inc first reported a position in Rentokil in Q4 2022 and has held it in 13 quarters since.
  • Ethic Inc's Rentokil position peaked at $1.38M in Q3 2023.
  • 282 funds tracked by Wall St. Rank held Rentokil as of Q1 2026.

Based on Ethic Inc's 13F filing for Q1 2026, filed 27 Apr 2026.